Skip to main content
. 2009 Oct 4;14(4):355–359. doi: 10.1111/j.1542-474X.2009.00325.x

Table 1.

Clinical and Exercise Characteristics of the Study Groups

Clinical Group 1 No MI, no DM (N = 54) Group 2 DM, no MI (N = 47) Group 3 MI, no DM (N = 26) Group 4 DM and MI (N = 13)
Age  53 ± 13 60 ± 10 58 ± 9  60 ± 8 
Gender: female [no. (%)] 10 (19) 12 (26)  4 (15) 1 (8)
BMI 27 ± 4 29 ± 6  27 ± 4  31 ± 5 
Insulin use [no. (%)] NA 11 (23) NA 4 (31)
HbA1c (%) NA 7.2 ± 1.4 NA 7.7 ± 1.5
Microvascular complications [no. (%)] NA  9 (19) NA 3 (23)
LV Ejection fraction (%) 61 ± 6 63 ± 7  53 ± 16 44 ± 11
Total cholesterol (mg/dL) 209 ± 45 175 ± 36  155 ± 32  167 ± 36 
Triglycerides (mg/dL) 132 ± 77 121 ± 66  131 ± 70  140 ± 65 
High density lipoprotein (mg/dL)  57 ± 16 45 ± 11 44 ± 9  40 ± 7 
Current smoker [no. (%)] 4 (7)  5 (11) 1 (4) 1 (8)
Hypertension [no. (%)] 17 (31) 30 (64) 11 (42) 11 (85)
Beta‐blocker use [no. (%)] 12 (22)  7 (15) 21 (81) 12 (92)
Statin use [no. (%)] 11 (20) 17 (36) 23 (89) 7 (54)
Exercise test data
Duration (seconds)  760 ± 169 652 ± 178 659 ± 201 582 ± 148
Resting HR (bpm)  75 ± 12 80 ± 13 65 ± 11 71 ± 13
Peak HR (bpm) 155 ± 23 141 ± 21  128 ± 21  128 ± 25 
HR 1 m post (bpm) 126 ± 23 122 ± 19  104 ± 20  111 ± 21 
Resting sBP (mmHg) 127 ± 17 126 ± 17  121 ± 19  137 ± 21 
Resting dBP (mmHg)  79 ± 11 76 ± 10 73 ± 8  79 ± 8 
Peak sBP (mmHg) 171 ± 23 175 ± 26  159 ± 20  180 ± 28 
Peak dBP (mmHg)  80 ± 11 76 ± 9  75 ± 7  84 ± 15
STD [no. (%)] 5 (9)  6 (13)  3 (12) 3 (23)

Data are number (%), or mean ± SD unless stated.

Microvascular complications—includes any combination of neuropathy, nephropathy, and/or retinopathy.

BMI = body mass index (wt in Kg/square of height in meters); HR = heart rate; LV = left ventricle; sBP = systolic blood pressure; dBP = diastolic blood pressure; STD = ischemic ST segment depression during exercise.